NeuMoDx introduces high-vol nucleic acid extraction capability

June 8, 2020—NeuMoDx Molecular released software that introduces “extraction only” capabilities among other enhancements. The extraction only feature provides users with an option for a faster extraction process, to enhance molecular testing. The NeuMoDx 288 and 96 molecular systems are capable of extracting DNA and RNA from about 400 and 200 samples in an eight-hour period, respectively.

“With the NeuMoDx Molecular solutions, our customers have had access to sophisticated, seamless workflows enabling continuous loading, true random access, and rapid turnaround times for sample-to-result IVD/LDT implementations,” Sundu Brahmasandra, NeuMoDx president and COO, said in a press release. “By extending these capabilities to include extraction only operation, our users can now harness the benefit of a high-throughput and universal nucleic acid extraction system that is able to simultaneously process a wide variety of clinical specimen matrices for high-quality DNA/RNA extractions.”